A phase II, multicenter study of bendamustine HCl plus rituximab in relapsed indolent B-cell and mantle-cell non-Hodgkin's lymphoma (NHL).
暂无分享,去创建一个
A. Tulpule | L. Schwartzberg | M. Williams | K. Robinson | R. Van der Jagt | B. Lemieux | A. Bessudo | J. Herst | J. Oliver | P. Cohen